NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SYK shares have decreased by 9.3% and is now trading at $159.22. View which stocks have been mosted impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Stryker.

Stryker Co. (NYSE:SYK) released its earnings results on Tuesday, January, 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.46 by $0.03. The medical technology company had revenue of $4.13 billion for the quarter, compared to analysts' expectations of $4.11 billion. Stryker had a net margin of 13.99% and a return on equity of 25.75%. The firm's revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.18 EPS. View Stryker's earnings history.

Stryker declared a quarterly dividend on Friday, February 7th. Investors of record on Tuesday, March 31st will be given a dividend of $0.575 per share on Thursday, April 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Monday, March 30th. View Stryker's dividend history.

Stryker issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided earnings per share guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus estimate of $9.04.

22 brokerages have issued 1-year target prices for Stryker's stock. Their forecasts range from $145.00 to $248.00. On average, they anticipate Stryker's share price to reach $217.35 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price. View analysts' price targets for Stryker.

News articles about SYK stock have been trending extremely negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Stryker earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutStryker.

Stryker saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 5,538,700 shares, an increase of 43.9% from the February 27th total of 3,850,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is presently 3.4 days. Currently, 1.6% of the shares of the stock are sold short. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Insulet (PODD), Steris (STE), Varian Medical Systems (VAR) and Masimo (MASI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Medtronic (MDT), Visa (V), Home Depot (HD), AbbVie (ABBV), Boeing (BA), NVIDIA (NVDA), QUALCOMM (QCOM) and Abbott Laboratories (ABT).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Greenleaf Trust (5.74%), State Street Corp (3.66%), FMR LLC (2.91%), Capital Research Global Investors (2.54%), Bank of New York Mellon Corp (1.86%) and Franklin Resources Inc. (1.52%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, FMR LLC, Nuveen Asset Management LLC, Capital International Investors, Alliancebernstein L.P., Massachusetts Financial Services Co. MA, Janus Henderson Group PLC, and Jensen Investment Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

SYK stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Renaissance Technologies LLC, Point72 Asset Management L.P., CWS Financial Advisors LLC, PGGM Investments, State Street Corp, Geode Capital Management LLC, and Schroder Investment Management Group. View insider buying and selling activity for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $159.22.

Stryker has a market capitalization of $59.64 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. View additional information about Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]